Melphalan Chemoreduction for Ocular Melanoma
Clinical trial NCT05893654 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05893654
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2025-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.